Winnable
Value
£30.4m
Stage
Early notice
Where
Scotland
Lots
3
Suitable for SMEs
Not stated
Contract
Not stated

Framework: winning a place puts you on an approved list for future work. It's the entry ticket, not guaranteed work.

In plain English

The Common Services Agency (Public Services Delivery Scotland) wants to set up a list of approved suppliers for Multiple Sclerosis medicines, split into 3 lots, with an estimated value of £30,403,887. A place on the list is the entry ticket to future orders, not guaranteed work; the contract dates and bid deadline are not stated.

Good fit for: Licensed pharmaceutical manufacturers or wholesalers able to supply MS medicines such as glatiramer acetate, interferon beta-1a or cladribine.

Written with AI. Always bid from the official notice.

What the buyer says

The Authority seeks to establish a Framework Agreement covering Multiple Sclerosis medicines. The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): Glatiramer acetate Interferon beta-1a Teriflunomide Dimethyl fumarate Fingolimod Natalizumab Cladribine

What happens next

This is an early notice: the buyer is planning a tender, and its documents come when the tender is published. Read the official notice for the details.

Procedure: not stated. Published 26 Oct 2026.

Similar open tenders

Want tenders like this, matched to your firm?

Winnable emails the few new tenders that fit you each weekday, with the catch spelled out. £29/month after a 14-day free trial (no card needed).

Start free trial